Search

The article discusses some of the missteps and miscalculations by different groups that left the Iraqi security forces weakened and vulnerable to the 2014 attack and invasion by the Islamic State of Iraq and Syria. Topics covered include the decision of the U.S. State Department to cut civilian programs and listening after the pullout of U.S. troops in 2011 and former State Secretary Hillary Clinton's support for a strong U.S. presence in Iraq.

The article examines the record of Democrat U.S. Presidential candidate Hillary Clinton in regulating the banking industry in the country as of November 2015. According to Clinton, she will be tough on the sector if elected president. Also examined are Clinton's mixed record on the industry, including her request for the voluntary suspension of foreclosures and a freeze on interest rates on adjustable subprime mortgages in 2007, as well as the bills she filed in the U.S. Senate.

The article reports that pharmaceutical company Johnson & Johnson has won a lawsuit alleging that its pain reliever Tylenol was defectively designed. The jury decided that plaintiff Regina Jackson, who had claimed that an overdose of the drug led to her hospitalization, failed to prove that she took Extra Strength Tylenol. McNeil Consumer Healthcare spokeswoman Jodie Wertheim noted that Tylenol has a long history of studies supporting its safety and efficacy.

The article reports on the controversy over the pain reliever Tylenol in the U.S. Internal company records have emerged in a trial pitting Tylenol maker McNeil Consumer Healthcare against a New Jersey woman who claims that she got hospitalized because of the drug. Previously undisclosed documents state that McNeil's regular surveys show that doctors recommended the drug, but they told patients to take the medication at lower doses. Doses near the recommended level could result in liver injury.

The article reports on efforts of the makers of Tylenol painkiller to block safety restrictions imposed by the U.S. Food and Drug Administration (FDA) on its chief ingredient acetaminophen. Topics discussed include study showing acetaminophen as a leading cause of liver failure across the U.S., suggestion of Jodie Wertheim, spokeswoman at McNeil, for customers to follow product label, and campaigns by McNeil Consumer Healthcare to block regulations imposed by FDA.

The article reports that Food and Drug administration (FDA) has approved endorsed introduction of flow restrictors which can help prevent children from taking too much acetaminophen, the active ingredient in Tylenol, which can cause liver damage if taken in high doses. The FDA has left the design of this product to the industry. The article also reports that the standards to test the efficacy of the product is expected in 2016 by American Society for Testing and Materials (ASTM).

The article discusses lawsuit by telecom consultant and whistelblower Todd Heath against AT&T and its unit Wisconsin Bell defrauding E-Rate, federal program subsidizing internet and telephone services to avert digial divide for schools and libraries, an appeals court in D.C. reviving both lawsuits under U.S. False Claims Act calling the AT&T case arise from a centralized and nationwide corporate policy. Article quotes AT&T that it complies with lowest corresponding price and E-Rate.

The article discusses Canada's top health agency's move to consider lowering the maximum daily dose of Acetaminophen in Tylenol and other painkillers, in the wake of the Canadian daily newspaper, Toronto Star's investigation results. Topics discussed include liver damage and deaths caused by drug overdose, excess dosage caused by taking several medicines containing acetaminophen, and Food and Drug Administration's slow progress in the monograph process to regulate over-the-counter drugs.

The article discusses the Food and Drug Administration's (FDA) investigation on the risk of brain deposits in patients, who are given repeated Magnetic Resonance Imaging scans (MRIs), and states that doctors should limit MRIs as image-enhancing drugs containing the metal gadolinium are used. It discusses the research on the nine agents used in the scan, the FDA's recommendation to avoid the drugs Omniscan, Magnevist and Optimark, and the studies by manufacturers to report gadolinium retention.

This article discusses the harmful effects of the drugs injected to help in enhancing MRI (Magnetic Resonance Imaging) scan images. It mentions the retaining of gadolinium based contrast agents like Omniscan and Magnevist produced by GE Health care and Bayer Healthcare respectively. It also briefs on the review of these two drugs by the United States Food and Drug Administration FDA as it contains a potential harmful toxic metal gadolinium that is wound up in the brain tissues of MRI patients.

The article inquires about the uncertainty of risk of asthma-related death posed by Advair asthma drug even after 15 years of its approval by the regulators.

The article discusses the hacked emails from the account of journalist Sydney Blumenthal that disclosed the information he sent to former Secretary of State Hillary Clinton regarding the militant attacks on the U.S. diplomatic outpost in Benghazi, Libya in 2012 that left four dead and 10 people injured. The hacked emails indicate that the information was gathered by a secret spy network that included a former clandestine service officer of the U.S. Central Intelligence Agency (CIA).

The article presents a list of the issues of political accountability by former U.S. Secretary of State Hillary Clinton from 1992 to 2015, which include campaigns on the release of commodity trade tax returns, issues of health care system reform and disclosures to the family foundation donors.

An excerpt from the book "Her Way: The Hopes and Ambitions of Hillary Rodham Clinton" by Jeff Gerth and Don Van Natta Jr. is presented which focuses on the improper used of personal email account by politician Hillary Clinton, during her tenure as U.S. secretary of state.